Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
73.9M
-
Shares change
-
+616K
-
Total reported value, excl. options
-
$1.89B
-
Value change
-
+$15.7M
-
Put/Call ratio
-
0.16
-
Number of buys
-
57
-
Number of sells
-
-40
-
Price
-
$25.51
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q1 2022
134 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q1 2022.
Revolution Medicines, Inc. - Common Stock (RVMD) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.9M shares
of 186M outstanding shares and own 39.79% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6.06M shares), TRV GP III, LLC (5.52M shares), BlackRock Inc. (5.34M shares), WELLINGTON MANAGEMENT GROUP LLP (4.08M shares), Nextech Invest AG (3.94M shares), BOXER CAPITAL, LLC (3.48M shares), Column Group LLC (3.35M shares), Bellevue Group AG (3.31M shares), FARALLON CAPITAL MANAGEMENT LLC (3.25M shares), and FMR LLC (2.87M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.